91295 ⎘
Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring; Halogenated derivatives monocyclic polyhydroxylic containing halogens bound to ring carbon atoms
NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS
#2PROCESSES FOR THE PREPARATION OF HALOGENATED DIHYDROXYBENZENE COMPOUNDS
#3Cannabinoid derivatives
#4REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS
#5Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex
#6Redox flow battery electrolytes
#7Process for preparing 3-chloro-2-vinylphenylsulfonates
#8Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
#9Synthesis of fluorinated radiopharmaceuticals via electrochemical fluorination
#10Compounds for use as inhibitors of alternative oxidase or cytochrome BC1 complex
#11Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof
#12Treatment of immune dysregulation using cannabinoid derivatives
#13Treatment Of Immune Dysregulation Using Cannabinoid Derivatives
#14Process for producing 1,2-dialkoxy-3-fluorobenzene
#15Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
#16METHODS AND AGENTS FOR TREATING TUBERCULOSIS
#17Process for producing cyclopropylphenol derivative
#18Methods for producing dibromofluorobenzene derivatives
#19Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
#20Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
#21Process for producing optically active chroman derivative and intermediate